Table 6 Survival estimates according to prophylactic glutamine use
Survival | Glutamine (+) | Glutamine (−) | P-value |
|---|---|---|---|
| Â | (N=56) | (N=48) | Â |
Overall | |||
Median (months) | 21.4 | 20.4 | 0.23 |
2-year (%) | 37.0 | 34.2 | Â |
3-year (%) | 27.8 | 22.8 | Â |
Locoregional progression free | |||
Median (months) | 11.3 | 14.2 | 0.11 |
2-year (%) | 18.7 | 16.4 | Â |
3-year (%) | 18.7 | 16.4 | Â |
Progression free | |||
Median (months) | 10.2 | 9.0 | 0.19 |
2-year (%) | 17.5 | 14.6 | Â |
3-year (%) | 17.5 | 14.6 | Â |